Literature DB >> 18253707

A variant transcript, e1a3, of the minor BCR-ABL fusion gene in acute lymphoblastic leukemia: case report and review of the literature.

Shinya Fujisawa1, Satoki Nakamura2, Kensuke Naito3, Masahide Kobayashi3, Kazunori Ohnishi4.   

Abstract

We report a rare case of adult Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) with an e1a3 fusion transcript. A 25-year-old female consulted our hospital for leukocytosis and thrombocytopenia. She was diagnosed with Ph-positive precursor B cell ALL. The patient's BCR-ABL fusion gene showed the e1a3 transcript. She received bone marrow transplantation (BMT) in the first complete remission (CR). However, the disease relapsed 4 months later, and she received a second BMT in the second CR, which caused lethal venoocculusive disease. The duration of the total clinical course was 18 months. We established a new cell line from the patient's leukemic cells at the time of relapse, which is very rare and useful for study as an atypical Ph-positive ALL model. The literature on Ph-positive leukemia lacking ABL exon 2 was also reviewed.

Entities:  

Mesh:

Year:  2008        PMID: 18253707     DOI: 10.1007/s12185-008-0031-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

1.  Rapid screening of leukemia fusion transcripts in acute leukemia by real-time PCR.

Authors:  Kazuoki Osumi; Takafumi Fukui; Hitoshi Kiyoi; Masanobu Kasai; Yoshihisa Kodera; Kazuko Kudo; Koji Kato; Takaharu Matsuyama; Kazuyuki Naito; Mitsune Tanimoto; Hisamaru Hirai; Hidehiko Saito; Ryuzo Ohno; Tomoki Naoe
Journal:  Leuk Lymphoma       Date:  2002-12

2.  Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.

Authors:  H M Kantarjian; S O'Brien; T L Smith; J Cortes; F J Giles; M Beran; S Pierce; Y Huh; M Andreeff; C Koller; C S Ha; M J Keating; S Murphy; E J Freireich
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

3.  A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  D Soekarman; J van Denderen; L Hoefsloot; M Moret; T Meeuwsen; J van Baal; A Hagemeijer; G Grosveld
Journal:  Leukemia       Date:  1990-06       Impact factor: 11.528

Review 4.  E1A3 as a unique, naturally occurring BCR-ABL transcript in an indolent case of chronic myeloid leukaemia.

Authors:  J Roman; A Jimenez; M Barrios; J A Castillejo; J Maldonado; A Torres
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998

5.  A novel 203 kD aberrant BCR-ABL product in a girl with Philadelphia chromosome positive acute lymphoblastic leukaemia.

Authors:  T Inukai; K Sugita; T Suzuki; K Ijima; K Goi; T Tezuka; S Kojika; K Hatakeyama; K Kagami; T Mori
Journal:  Br J Haematol       Date:  1993-12       Impact factor: 6.998

6.  A rare, in-frame BCR-ABL fusion (e13a3) in a patient with an aggressive chronic myeloid leukaemia.

Authors:  Ivone B Otazú; María Belén Rivero; Renata Olício; Augusto Pinto; Ilana Zalcberg; Héctor N Seuánez
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

7.  Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience.

Authors:  E Paietta; J Racevskis; J M Bennett; D Neuberg; P A Cassileth; J M Rowe; P H Wiernik
Journal:  Leukemia       Date:  1998-12       Impact factor: 11.528

Review 8.  Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3.

Authors:  Li-Gen Liu; Hideo Tanaka; Kinro Ito; Taiichi Kyo; Takuo Ito; Akiro Kimura
Journal:  Am J Hematol       Date:  2003-12       Impact factor: 10.047

Review 9.  Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2.

Authors:  S Iwata; S Mizutani; S Nakazawa; J Yata
Journal:  Leukemia       Date:  1994-10       Impact factor: 11.528

10.  Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.

Authors:  M Nieborowska-Skorska; M A Wasik; A Slupianek; P Salomoni; T Kitamura; B Calabretta; T Skorski
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

View more
  9 in total

1.  Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report.

Authors:  Michele Massimino; Stefania Stella; Elena Tirrò; Maria Letizia Consoli; Maria Stella Pennisi; Adriana Puma; Silvia Rita Vitale; Chiara Romano; Valentina Zammit; Fabio Stagno; Francesco Di Raimondo; Livia Manzella
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

2.  Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript.

Authors:  Sang-Yong Shin; Jin-Hee Cho; Hee-Jin Kim; Jun-Ho Jang; Seung-Tae Lee; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

3.  Aleukemic Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia with E1A3 BCR-ABL1 Fusion Transcript.

Authors:  Naoki Miyashita; Masahiro Onozawa; Keito Suto; Shinichi Fujisawa; Nanase Okazaki; Daisuke Hidaka; Hiroyuki Ohigashi; Atsushi Yasumoto; Junichi Sugita; Daigo Hashimoto; Yoshihiro Matsuno; Takanori Teshima
Journal:  Intern Med       Date:  2021-09-11       Impact factor: 1.282

4.  A rare e14a3 (b3a3) BCR-ABL fusion transcript in chronic myeloid leukemia: diagnostic challenges in clinical laboratory practice.

Authors:  Natini Jinawath; Alexis Norris-Kirby; B Douglas Smith; Christopher D Gocke; Denise A Batista; Constance A Griffin; Kathleen M Murphy
Journal:  J Mol Diagn       Date:  2009-06-04       Impact factor: 5.568

5.  Optimal Molecular Methods in Detecting p190 (BCR-ABL) Fusion Variants in Hematologic Malignancies: A Case Report and Review of the Literature.

Authors:  Rebecca J Sonu; Brian A Jonas; Denis M Dwyre; Jeffrey P Gregg; Hooman H Rashidi
Journal:  Case Rep Hematol       Date:  2015-04-08

6.  Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases.

Authors:  Bernardo López-Andrade; Francesca Sartori; Antonio Gutiérrez; Lucia García; Vanesa Cunill; María Antonia Durán; Antonia Sampol; Marta Bernués; Julio Iglesias; Rafael Ramos; Josep Lladó; María Sánchez; Juan Carlos Amat; Jordi Martínez-Serra
Journal:  Exp Hematol Oncol       Date:  2016-07-29

7.  Variant BCR-ABL1 fusion genes in adult Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia.

Authors:  Stephen E Langabeer
Journal:  EXCLI J       Date:  2017-10-18       Impact factor: 4.068

8.  The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias.

Authors:  Stefania Stella; Enrico Marco Gottardi; Valeria Favout; Eva Barragan Gonzalez; Santa Errichiello; Silvia Rita Vitale; Carmen Fava; Luigia Luciano; Fabio Stagno; Francesco Grimaldi; Lucrezia Pironi; Claudia Sargas Simarro; Paolo Vigneri; Barbara Izzo
Journal:  Int J Mol Sci       Date:  2019-12-04       Impact factor: 5.923

9.  Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis.

Authors:  Jordi Martinez-Serra; Raquel Del Campo; Antonio Gutierrez; Jose Luis Antich; Magdalena Ginard; Maria A Durán; Leyre Bento; Teresa Ros; Juan C Amat; Carmen Vidal; Julio F Iglesias; Izabela Orlinska; Joan Besalduch
Journal:  Biomark Res       Date:  2014-08-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.